Active, not recruitingPhase 2NCT03474094

Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Leon Berard
Principal Investigator
Jean-Yves BLAY, MD
Centre Leon Berard
Intervention
Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery(combination_product)
Enrollment
62 target
Eligibility
18 years · All sexes
Timeline
2018 – 2026

Study locations (6)

Collaborators

Roche Pharma AG

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03474094 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma →

← Back to all trials